|
|
||||||||
Cardiovascular Institute, University of Pittsburgh Health System, Pittsburgh, Pennsylvania 15213
Transgenic (TG) TNF1.6
mice, which cardiac specifically overexpress tumor necrosis factor-
(TNF-
), exhibit heart failure (HF) and increased mortality, which is
markedly higher in young (<20 wk) males (TG-M) than females (TG-F). HF
in this model may be partly caused by remodeling of the extracellular
matrix and/or structure/function alterations at the single myocyte
level. We studied left ventricular (LV) structure and function using
echocardiography and LV myocyte morphometry, contractile function, and
intracellular Ca2+ (Ca
-myosin heavy chain and atrial natriuretic factor versus TG-F mice,
reduced FS relative to both WT and TG-F mice, and minimal response to
Iso. TG-F and TG-M myocytes were similarly elongated (by
20%). The
amplitude of Ca




induces myocyte hypertrophy
and gender-dependent alterations in Ca
transgenic mice; gender; heart failure; calcium; echocardiography
This article has been cited by other articles:
![]() |
J.-B. Shen, R. Shutt, M. Agosto, A. Pappano, and B. T. Liang Reversal of cardiac myocyte dysfunction as a unique mechanism of rescue by P2X4 receptors in cardiomyopathy Am J Physiol Heart Circ Physiol, April 1, 2009; 296(4): H1089 - H1095. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Sanchis, M. Llovera, M. Ballester, and J. X. Comella An alternative view of apoptosis in heart development and disease Cardiovasc Res, February 1, 2008; 77(3): 448 - 451. [Full Text] [PDF] |
||||
![]() |
J.-B. Shen, R. Shutt, A. Pappano, and B. T. Liang Characterization and mechanism of P2X receptor-mediated increase in cardiac myocyte contractility Am J Physiol Heart Circ Physiol, November 1, 2007; 293(5): H3056 - H3062. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S. Petkova-Kirova, E. Gursoy, H. Mehdi, C. F. McTiernan, B. London, and G. Salama Electrical remodeling of cardiac myocytes from mice with heart failure due to the overexpression of tumor necrosis factor-{alpha} Am J Physiol Heart Circ Physiol, May 1, 2006; 290(5): H2098 - H2107. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Saba, A. M. Janczewski, L. C. Baker, V. Shusterman, E. C. Gursoy, A. M. Feldman, G. Salama, C. F. McTiernan, and B. London Atrial contractile dysfunction, fibrosis, and arrhythmias in a mouse model of cardiomyopathy secondary to cardiac-specific overexpression of tumor necrosis factor-{alpha} Am J Physiol Heart Circ Physiol, October 1, 2005; 289(4): H1456 - H1467. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Kawamura, T. Kubota, S. Kawano, Y. Monden, A. M. Feldman, H. Tsutsui, A. Takeshita, and K. Sunagawa Blockade of NF-{kappa}B improves cardiac function and survival without affecting inflammation in TNF-{alpha}-induced cardiomyopathy Cardiovasc Res, June 1, 2005; 66(3): 520 - 529. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ikeuchi, H. Tsutsui, T. Shiomi, H. Matsusaka, S. Matsushima, J. Wen, T. Kubota, and A. Takeshita Inhibition of TGF-{beta} signaling exacerbates early cardiac dysfunction but prevents late remodeling after infarction Cardiovasc Res, December 1, 2004; 64(3): 526 - 535. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Ramani, M. Mathier, P. Wang, G. Gibson, S. Togel, J. Dawson, A. Bauer, S. Alber, S. C. Watkins, C. F. McTiernan, et al. Inhibition of tumor necrosis factor receptor-1-mediated pathways has beneficial effects in a murine model of postischemic remodeling Am J Physiol Heart Circ Physiol, September 1, 2004; 287(3): H1369 - H1377. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. P.M van Empel and L. J De Windt Myocyte hypertrophy and apoptosis: a balancing act Cardiovasc Res, August 15, 2004; 63(3): 487 - 499. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-J. Du Gender modulates cardiac phenotype development in genetically modified mice Cardiovasc Res, August 15, 2004; 63(3): 510 - 519. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. MacGowan, C. Evans, T. C.-C. Hu, D. Debrah, S. Mullet, H.-H. Chen, C. F. McTiernan, A. F.R. Stewart, A. P. Koretsky, and S. G. Shroff Troponin I protein kinase C phosphorylation sites and ventricular function Cardiovasc Res, August 1, 2004; 63(2): 245 - 255. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M Janczewski, M. Zahid, B. H Lemster, C. S Frye, G. Gibson, Y. Higuchi, E. G Kranias, A. M Feldman, and C. F McTiernan Phospholamban gene ablation improves calcium transients but not cardiac function in a heart failure model Cardiovasc Res, June 1, 2004; 62(3): 468 - 480. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Aravamudan, D. Volonte, R. Ramani, E. Gursoy, M. P. Lisanti, B. London, and F. Galbiati Transgenic overexpression of caveolin-3 in the heart induces a cardiomyopathic phenotype Hum. Mol. Genet., November 1, 2003; 12(21): 2777 - 2788. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |